SENTI BIOSCIENCES INC (SNTI)

US81726A1007 - Common Stock

3.95  +0.05 (+1.28%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
2.76M
384.21%
4.29M
55.43%
2.561M
-40.30%
2.856M
11.52%
5.1M
78.57%
3.876M
-24.00%
2.346M
-39.47%
30.702M
1,208.70%
125.66M
309.29%
300.39M
139.05%
EBITDA
YoY % growth
-39.68M
-64.44%
-69.23M
-74.47%
-63.204M
8.70%
-64.26M
-1.67%
-61.2M
4.76%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
-40.45M
-63.83%
-70.63M
-74.61%
-66.765M
5.47%
-64.26M
3.75%
-61.2M
4.76%
N/AN/AN/AN/AN/A
Operating Margin
-1,465.58%-1,646.39%-2,606.99%-2,250.00%-1,200.00%N/AN/AN/AN/AN/A
EPS
YoY % growth
N/AN/AN/A
91.40%
-14.83
-848.26%
-1.92
87.07%
N/AN/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth
2.40
163.16%
-4.526.92153.07%
Q2 2023
Q2Q % growth
-4.20 -4.860.6613.62%
Q1 2023
Q2Q % growth
-4.20 -4.420.224.98%
Q4 2022
Q2Q % growth
-4.20 -4.460.265.88%
Q3 2022
Q2Q % growth
-3.80 -4.660.8618.42%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth
338K
-80.90%
714K-376K-52.66%
Q2 2023
Q2Q % growth
937K
-31.10%
510K427K83.73%
Q1 2023
Q2Q % growth
1.286M
16.91%
476.003K809.997K170.17%
Q4 2022
Q2Q % growth
60K
-92.41%
1.571M-1.511M-96.18%
Q3 2022
Q2Q % growth
1.77M
60.91%
947.07K822.93K86.89%
Q2 2022
Q2Q % growth
1.36M
72.15%
%
Q1 2022
Q2Q % growth
1.1M
1,471.43%
%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A -1825.83% -1825.83%
RevenueN/A N/A -68.54% -68.54%